Photo

613.801.1082

...

Ottawa

English

Evgenia Apelfeld, MBA

Director of Business Development & Marketing

Evgenia joined MBM in January of 2014 and is spearheading MBM’s Marketing & Business Development Department. She is responsible for building and maintaining relationships with foreign associates and foreign filing assignment at MBM.

On the Marketing front, she has extensive experience in all aspects of Marketing and Communications with more than 15 years experience in a variety of industries including technology and professional services sector. In her past roles, in addition to her marketing function, she also developed and taught marketing, communications and social media courses for internal staff and was part of the recruitment and talent management committees.

Evgenia has a B.Comm. in Marketing and an MBA from the University of Ottawa. She specializes in content marketing, digital marketing, social media and event management, but has a passion for the field of Marketing as a whole. She speaks three languages: English, Russian and Hebrew.

Evgenia is an avid travel and food enthusiast and enjoys planning her next travel destination and picking the next restaurant to try. She also has a huge passion for basketball and is a big fan of the Toronto Raptors and the Golden State Warriors.

Education

  • B.Comm. Marketing - University of Ottawa
  • MBA - University of Ottawa

Professional Involvement

  • Legal Marketing Association (LMA)
  • Pharmaceutical Trade Marks Group (PTMG)
  • Intellectual Property Owners Association (IPO)

  • Association of Intellectual Property Firms (AIPF)

  • Asian Patent Attorneys Association (APAA)

Practice Area

cb photo 103 56182ad806034

RANDALL MARUSYK

Partner


Randall is a partner of the firm and has been certified as a specialist in all areas of Canadian IP Law.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More